![Georges Gaudriault](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Georges Gaudriault
Direttore Tecnico/Scientifico/R&S presso DEINOVE
Profilo
Georges Gaudriault is currently the Chief Scientific Officer at Deinove SA. Previously, he held positions as the Scientific Director at Obe Therapy Biotechnology SAS, Obetherapy, and MedinCell SA. Dr. Gaudriault obtained his undergraduate, graduate, and doctorate degrees from the University of Nice Sophia Antipolis.
Posizioni attive di Georges Gaudriault
Società | Posizione | Inizio |
---|---|---|
DEINOVE | Direttore Tecnico/Scientifico/R&S | 23/05/2017 |
Precedenti posizioni note di Georges Gaudriault
Società | Posizione | Fine |
---|---|---|
Obe Therapy Biotechnology SAS
![]() Obe Therapy Biotechnology SAS Medical/Nursing ServicesHealth Services Obe Therapy Biotechnology SAS Discovers and develops therapeutics and novel drugs for obesity. The firm focuses on the genetics of lean and hypolipidemic phenotype. The company was founded by Itzik Harosh in January 2000 and is headquartered in Evry, France. | Direttore Tecnico/Scientifico/R&S | - |
Obetherapy
![]() Obetherapy Pharmaceuticals: MajorHealth Technology Obetherapy is a French biotech company that focuses on developing new drugs for obesity and hypercholesterolemia. | Direttore Tecnico/Scientifico/R&S | - |
MEDINCELL S.A. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Georges Gaudriault
University of Nice Sophia Antipolis | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
MEDINCELL S.A. | Health Technology |
Aziende private | 3 |
---|---|
Deinove SA
![]() Deinove SA BiotechnologyHealth Technology Deinove SA is a biotechnology company, which engages in the development of new-generation anti-infective antibiotics and bioactives. Its portfolio include Phy-N-Resist and HEBELYS. The company was founded by Philippe Pouletty and Miroslav Radman on October 11, 2006 and is headquartered in Grabels, France. | Health Technology |
Obe Therapy Biotechnology SAS
![]() Obe Therapy Biotechnology SAS Medical/Nursing ServicesHealth Services Obe Therapy Biotechnology SAS Discovers and develops therapeutics and novel drugs for obesity. The firm focuses on the genetics of lean and hypolipidemic phenotype. The company was founded by Itzik Harosh in January 2000 and is headquartered in Evry, France. | Health Services |
Obetherapy
![]() Obetherapy Pharmaceuticals: MajorHealth Technology Obetherapy is a French biotech company that focuses on developing new drugs for obesity and hypercholesterolemia. | Health Technology |
- Borsa valori
- Insiders
- Georges Gaudriault